En español

No added benefit from risk-reduction counseling at HIV testing

Science Spotlight

October 23, 2013

HIV Rapid testing product showing DVD

For persons at risk for HIV, brief risk-reduction counseling at the time of a rapid HIV test does not reduce new sexually transmitted infections in a six-month follow-up. This counseling also did not reduce rates of unprotected sex, according to a study published in JAMA.

Risk-reduction counseling has historically played a major role in the HIV testing process; however these results suggest that to use resources more efficiently, clinics should reconsider their approach to providing information at the time of testing. Post-test counseling for persons testing HIV-positive remains essential.

For a copy of the study, go to http://jama.jamanetwork.com/article.aspx?articleid=1758751. For a copy of a press release from JAMA, go to http://media.jamanetwork.com/news-item/brief-risk-reduction-counseling-time-hiv-testing-result-reduction-rate-stis/. For more information on HIV rapid testing in substance abuse treatment programs, go to: www.drugabuse.gov/blending-initiative/hiv-rapid-testing.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245.

NIDA Press Office

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

News Releases










Get this Publication

    Receive Latest Science Articles in your Email!
    You will only receive messages related to Latest Science
    Cite this article

    NIDA. (2013, October 23). No added benefit from risk-reduction counseling at HIV testing. Retrieved from https://www.drugabuse.gov/news-events/news-releases/2013/10/no-added-benefit-risk-reduction-counseling-hiv-testing

    press ctrl+c to copy